Merck Sharp & Dohme Corp. vs. Ono Pharmaceutical Co., Ltd.
Explore the PTAB proceeding IPR2016-01221 filed by Merck Sharp & Dohme Corp. on 2016-06-29. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2016-01221
Filing Date
2016-06-29
Accorded Filing Date
2016-06-29
Institution Decision Date
โ
Last Modified Date
2018-06-21
Proceeding Type
IPR
Termination Date
2017-01-25
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Merck Sharp & Dohme Corp.
Represented By
Jeffrey KushanPatent Owner / Respondent
Ono Pharmaceutical Co., Ltd.
Represented By
Eldora EllisonPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 28912 | Robert Sterne | +1 202-772-8555 |
| 29021 | Jorge Goldstein | +1 202-371-2600 |
| 32705 | Elliott Korsen | +1 609-252-4741 |
| 32831 | Tracy-Gene Durkin | +1 202-371-2600 |
| 33876 | Donald Featherstone | +1 202-772-8629 |
| 33997 | Michael Ray | +1 202-772-8569 |
| 34395 | Robert Millonig | +1 202-371-2600 |
| 35239 | Michael Lee | +1 703-628-0233 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
Merck Sharp & Dohme Corp. v. Ono Pharmaceutical Co., Ltd.
Bristol-Myers Squibb Co. v. EMD Serono, Inc.
Bristol-Myers Squibb Co. v. Merck & Co., Inc.
Bristol-Myers Squibb Co. v. Merck & Co., Inc.
Bristol-Myers Squibb Co. v. Merck & Co Inc.
Standard Essential Patent (SEP) & FRAND Intelligence
5G SEP โข ETSI Declared High-Probability SEP ActionEssential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation
Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)
Permanent Injunction RestrictedAsserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.